晶状体超声乳化负屈光度人工晶状体植入矫正高度近视22例

Phacoemulsification and negative dio-pter intraocular lens implantation for cor-rection of high myopia in 22 cases

目的:评价晶状体超声乳化负屈光度人工晶状体植入术对高度近视治疗的可行性、有效性、安全性。方法:对22例(31眼)高度近视患者行超声乳化联合负屈光度人工晶状体植入,观察术中、术后并发症,术后视力、术后屈光度等,术后随诊≥3mo。结果:术后矫正视力<0.1者2眼,0.1～0.4者6眼,0.5～0.9者19眼,≥1.0者4眼。术中无并发症发生。术后4眼(13%)后囊膜混浊,无视网膜脱离、眼底出血等并发症发生。结论:晶状体超声乳化负屈光度人工晶状体植入矫正高度近视是一种安全、有效、可行的方法。

· AIM: To evaluate the feasibility, safety and effectiveness of phacoemulsificaion and negative diopter intraocular lens implantation for correction of high mopia.· METHODS: twenty-two patients (31 eyes) with high myopia received phacoemulsification and negative diopter intraocular lens implantation. Intraoperative and postoperative complications, postoperative visual acuity and postoperative refraction were observed.· RESULTS: Postoperatively, best corrected visual acuity (BCVA) was less than 0.1 in 2 eyes, 0.1-0.4 in 6 eyes, 0.5-0.9 in 19 eyes and more than 1.0 in 4 eyes. No intraoperative complication occurred. Posterior capsular turbidity was found in 4 eyes. No other postoperative complications such as retinal detachment and eyeground bleeding occurred. Follow-up period was 3-9mo and the average follow-up period was 5mo.· CONCLUSION: phacoemulsification combined with negative diopter intraocular lens implantation is an effective, safe and feasible way to correct high myopia.·